Discover when microarrays are preferred in the age of NGS

In this webinar, Shashi Shetty, Ph.D., addresses the question, "When are microarrays the preferred choice for genetic testing in the age of next-generation sequencing (NGS)?" There are multiple factors that can influence the choice to implement microarrays in a testing regime or to decide which technology is best for a given scenario.

Key learnings:

  • Understand appropriate indications for SNP/chromosomal microarray (CMA) testing in a postnatal setting
  • Explain why hybrid-SNP array is still a robust test in the age of newer molecular technologies
  • Discuss interesting cases to support the clinical utility of hybrid-SNP arrays and various approaches for final interpretation
Dr. Shashi Shetty, Ph.D.

Dr. Shashi Shetty, Ph.D.,
Associate Professor of the Department of Pathology, School of Medicine at Case Western Reserve University

Complete the form below to watch the on-demand webinar.

(*Indicates a mandatory field)